Chandler H. Park
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Prostate Cancer Treatment and Research 6
- Renal cell carcinoma treatment 2
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 2
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- Radiation top 10%
-
- Bladder and Urothelial Cancer Treatments 4
-
- Mass Spectrometry Techniques and Applications 2
- Co-authors
- Scott T. TagawaLuke T. NordquistKen HerrmannMichelle DeSilvioKarim FizaziTomasz M. BeerGermo GerickeBernd J. Krause
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (7 papers)Journal of Hematology & Oncology (1 paper)
- Partner nations
- United StatesItalyGeorgia
In The Last Decade
Chandler H. Park
19 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Radiology, Nuclear Medicine and Imaging 1.1k
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 602
- Cancer Research 198
- Radiation 55
Countries citing papers authored by Chandler H. Park
This map shows the geographic impact of Chandler H. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandler H. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandler H. Park more than expected).
Fields of papers citing papers by Chandler H. Park
This network shows the impact of papers produced by Chandler H. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandler H. Park. The network helps show where Chandler H. Park may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chandler H. Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 33 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 12 | |
| 15 | 2022 | 28 | |
| 16 | 2022 | 7 | |
| 17 | 2021 | 2 | |
| 18 | 2021 | 54 | |
| 19 | Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancerbreakdown → | 2021 | 1487 |
| 20 | Nicotine does not reduce blood flow to healthy bone in rats. | 2008 | 1 |
About Chandler H. Park
Chandler H. Park is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Prostate Cancer Treatment and Research (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Genomics and Diagnostics (3 papers), Renal cell carcinoma treatment (2 papers), Mass Spectrometry Techniques and Applications (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Oncology (602 citations). Chandler H. Park has collaborated with scholars based in United States, Italy and Georgia. Frequent co-authors include Scott T. Tagawa, Luke T. Nordquist, Ken Herrmann, Michelle DeSilvio, Karim Fizazi, Tomasz M. Beer, Germo Gericke, Bernd J. Krause, Johann S. de Bono and Michael J. Morris. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.